🇺🇸 FDA
Patent

US 10369173

Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy

granted A61KA61K35/00A61K35/34

Quick answer

US patent 10369173 (Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy) held by Capricor, Inc. expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Capricor, Inc.
Grant date
Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K35/00, A61K35/34, A61P, A61P9/00